United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Sep 22, 2026 · Filed Sep 23, 2026

On Sep 22, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$494.83 for US$4.7M under a trading plan, leaving 324,443 shares. Filed Sep 23, 2026 (Form 4).

Sold
9,500 shares
Price
US$494.83 average (US$489.61 to US$499.07)
Value
US$4.7M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 22, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Sep 22, 2026Common StockSale240US$489.61333,703Indirect
Sep 22, 2026Common StockSale424US$490.54333,279Indirect
Sep 22, 2026Common StockSale736US$491.45332,543Indirect
Sep 22, 2026Common StockSale628US$492.67331,915Indirect
Sep 22, 2026Common StockSale1,645US$493.70330,270Indirect
Sep 22, 2026Common StockSale1,337US$494.66328,933Indirect
Sep 22, 2026Common StockSale1,488US$495.77327,445Indirect
Sep 22, 2026Common StockSale1,484US$496.83325,961Indirect
Sep 22, 2026Common StockSale1,358US$497.73324,603Indirect
Sep 22, 2026Common StockSale160US$499.07324,443Indirect

Source

View original at SEC

Related